Kimberly K Egan

Kimberly K Egan

0.0
Not yet reviewed Write a Review
Rating: 8.5

Licensed for 28 years

Life sciences and biotechnology Lawyer at Woodbine, MD
Practice Areas: Life Sciences & Biotechnology, Litigation

3435 Jennings Chapel Road, Woodbine, MD

About Kimberly

Practice Areas

2

Practice Areas

Fees and Rates

We have not found any cost information for this lawyer


Looking for an attorney? Avvo can help.

search module image

Search our directory

Quickly connect with top attorneys through our legal directory to get help with your legal issue.

chat module image

Avvo's live chat agents can help coordinate a consultation with a local attorney.

Chat with a live agent who can match you with the right attorney for your legal needs.

Chat with

Licenses

Licensed in District of Columbia for 27 years

State: District of Columbia

Acquired: 1999

Administratively Suspended - Non-Payment of Dues

No misconduct found

Licensed in New York for 28 years

State: New York

Acquired: 1998

Suspended

No misconduct found

Location

Saltbox Consulting

3435 Jennings Chapel Road, Woodbine, MD, 21797

Saltbox Consulting

3435 Jennings Chapel Rd, Woodbine, MD, 21797-7509

Ad

Transform legal challenges into solutions.

Connect now to review your situation.

The Avvo Rating explained

display-bg

The Avvo Rating explained

Kimberly K Egan's Reviews

Avvo Review Score

0.0 /5.0

Not Yet Reviewed

Kimberly K Egan's Lawyer Endorsements

Endorse Kimberly

No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.

No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.

Experience

Rating:  8.5 (Excellent)

Work Experience

2012 - Present

Founder, Saltbox Consulting

2005 - 2012

Partner, DLA Piper, LLP

1997 - 2005

Associate, Covington & Burling

Education

1997

Duke University School of Law

JD - Juris Doctor

1992

Columbia University

BA - Bachelor of Arts

Speaking Engagements

2013

Biopharmaceuticals Good Distribution Practices Summit, Bethesda, Maryland (Mar. 20, 2013)

Track-and-Trace: Selected Regulatory Requirements

2013

Biopharmaceuticals Good Distribution Practices Summit, Bethesda, Maryland (Mar. 19, 2013).

Quality Agreements: Managing Contract Distributors

2013

Advertising & Promotion Conference, Washington, D.C.

Best Practices for Compliance in Gray Areas

2010

Hong Kong Productivity Council & Federation of Hong Kong Industries, Hong Kong (Jan. 22, 2010).

Trends and Developments in Consumer Product Enforcement and Litigation

2010

Clinical R&D Compliance Forum, Philadelphia (June 28-29, 2010)

Clinical R&D Compliance

2010

Ass’n of Corporate Counsel, Baltimore Chapter, Baltimore, Maryland (Jan. 27, 2010).

Global Supply Chains Issues in the Global Era: Prevention, Protection and Compliance

2010

Association of Corporate Counsel, San Francisco Bay Area Chapter (April 27 and 29, 2010).

Supply Chain Challenges in the New Regulatory Environment

2009

Hot Topics in Regulatory Affairs Workshop, San Diego, CA (June 23, 2009).

The Impact on Emerging Growth Companies of Issues Affecting FDA Regulations and Compliance

2009

Ass’n for Corporate Counsel Chicago Chapter, Chicago, Illinois (July 22, 2009).

Global Supply Chains in the Global Era: Prevention, Protection and Compliance

2008

Webinar (Oct. 28, 2008).

Shoring up Weak Links in the Pharmaceutical Supply Chain

2006

Webinar, (July 18, 2006).

Drug Development and Approval: A Partnership Between FDA and Industry

2002

D.C. Bar Association Lunch Program, Summer 2002

Issues Facing Women Litigators

Publications

2013

FDLI’S FOOD & DRUG POL’Y FORUM, Vol. 3, No. 2 (Dec. 11, 2013). Is It Time for Harmonized Cosmetics Standards? A Comparison of U.S. and E.U. Cosmetics Regulations

2012

THE SCIENTIST Regulations For Biosimilars: As Biologic Drug Patents Begin to Expire, Generic Versions Will Hit the Market, But How Will They Be Regulated?

2011

NATIONAL LAW J., Feb. 28, 2011 What Associates Didn't Learn in Law School

2011

GETTING THE DEAL THROUGH: LIFE SCIENCES GETTING THE DEAL THROUGH: LIFE SCIENCES (US CHAPTER)

2010

GETTING THE DEAL THROUGH: LIFE SCIENCES GETTING THE DEAL THROUGH: LIFE SCIENCES (US Chapter)

2009

FOR THE DEFENSE, International Law Section, March 2009 Made in China: Five Opportunities Created by the Recent Recalls

2009

FINANCIER WORLDWIDE, July 2009 Mitigating Corporate Corruption in the Healthcare Industry

2009

RICHMOND MAGAZINEONLINE.COM, Dec./Jan. 2009. The China Syndrome: Five Lessons to Learn from Recent Scandals Involving Chinese Products

2009

Member Briefings, AMERICAN HEALTH LAWYERS ASS’N Does FDA's 'Changes Being Effected' Final Rule Really Change Anything?

2001

NATIONAL LAW J., June 25, 2001 Genetically Modified Foods Raise New Legal Issues
Avvo Rating

Our Rating is calculated using information the lawyer has included on their profile in addition to the information we collect from state bar associations and other organizations that license legal professionals. Attorneys who claim their profiles and provide Avvo with more information tend to have a higher rating than those who do not.

What determines Avvo Rating?
  • Experience & background Years licensed, work experience, education
  • Legal community recognition Peer endorsements, associations, awards
  • Legal thought leadership Publications, speaking engagements
  • Discipline Disciplinary information may not be comprehensive, or updated. We recommend that you always check a lawyer's disciplinary status with their respective state bar association before hiring them.
Avvo Rating Levels
10.0 - 9.0 Superb8.9 - 8.0 Excellent7.9 - 7.0 Very Good6.9 - 6.0 Good5.9 - 5.0 Average4.9 - 4.0 Concern3.9 - 3.0 Caution2.9 - 2.0 Strong Caution1.9 - 1.0 Extreme Caution